Navigation Links
M. D. Anderson Cancer Center Researchers to Present CTCE-9908 Data,at the AACR Annual Meeting

als" survey four out of the past six years.

About Chemokine Therapeutics Corp.

Chemokine Therapeutics is a product-focused biotechnology company developing drugs in the field of chemokines. Chemokines are a class of signaling proteins which play a critical role in the growth, differentiation, and maturation of cells necessary for fighting infection as well as tissue repair and regeneration. Chemokines also have an important role in cancer metastasis and growth. Chemokine Therapeutics is a leader in research in the field of chemokines and has several products in various stages of development.

Safe Harbor Statement under the U. S. Private Securities Litigation Reform Act of 1995: Statements in this document regarding managements' future expectations, beliefs, goals, plans or prospects constitute forward-looking statements that involve risks and uncertainties, which may cause actual results to differ materially from the statements made. For this purpose, any statements that are contained herein that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words "believes", "anticipates", "plans", "intends", "will", "should", "expects", "projects", and similar expressions are intended to identify forward-looking statements. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause actual results, future circumstances, or events to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, those associated with the success of research and development programs, the regulatory approval process, competition, securing and maintaining corporate alliances, market acceptance of the Company's products, the availability of government and insurance reimbursements for the Company's products, the strength of intellectual property, financing capability, the potential dilutive effects of an
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Dasatinib Shows High Early Response Rate as First Treatment for Chronic Myelogenous Leukemia, M. D. Anderson Researchers Report
2. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
5. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
6. Protox Announces Positive Clinical Data from Prostate Cancer Study
7. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
8. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
9. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
10. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
11. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
Post Your Comments:
(Date:8/22/2014)... -- Research and Markets  has announced the addition ... & Technologies" report to their offering. ... or you wish to expand your product line, you,ll ... The authors know you want to make effective product ... generate improved revenues and take market share from your ...
(Date:8/22/2014)... , Aug. 22, 2014 Research ... "Global and Chinese Particulate Respirators Industry Report 2014" ... Global and Chinese Particulate Respirators Industry Report 2014 is ... of the global particulate respirators industry with a focus ... basic overview of the industry including definitions, classifications, applications ...
(Date:8/22/2014)... Ill. , Aug. 22, 2014  Landauer, Inc. ... personal and environmental radiation measurement and monitoring, outsourced medical ... today that William E. Saxelby , its President ... President and Chief Executive Officer and as a member ... 15, 2014.  He will be replaced on an interim ...
Breaking Medicine Technology:Global Stem Cell Research Products: Opportunities, Tools & Technologies - 2014 Report 2Global Stem Cell Research Products: Opportunities, Tools & Technologies - 2014 Report 3Global and Chinese Particulate Respirators Industry Report 2014 2Landauer, Inc. Announces Executive Management Change 2
... 29, 2011 A woman,s face tells her story but ... surgery, fillers, lasers and more, the quest continues for new ...  According to the new Face Forward survey commissioned by ... aesthetics cleared by the FDA with a non-invasive lift indication), ...
... LLC, a private biotechnology company focused on the treatment ... announced publication of promising preclinical data demonstrating that the ... diabetes in a mouse model.  The results of the ... of Rejuvenation Research and available currently ...
Cached Medicine Technology:What Would Women Give Up for a More Youthful Face? 2What Would Women Give Up for a More Youthful Face? 3Pathfinder Cells Demonstrate Ability to Regenerate Damaged Tissue and Restore Pancreatic Function in a Diabetic Mouse Model 2Pathfinder Cells Demonstrate Ability to Regenerate Damaged Tissue and Restore Pancreatic Function in a Diabetic Mouse Model 3Pathfinder Cells Demonstrate Ability to Regenerate Damaged Tissue and Restore Pancreatic Function in a Diabetic Mouse Model 4
(Date:8/22/2014)... August 22, 2014 Japantown Dental is ... new teeth whitening technique. Air polishing is a technique ... , Dark teeth can be caused by a number ... stains and internal stains. External stains include coffee, wine, ... caused by certain medications, such as tetracycline, and direct ...
(Date:8/22/2014)... 2014 Recently, iFitDress.com, a well-known wedding ... of discounted wedding gowns . In addition to ... these new products are provided with low shipping fees. ... to unveil the new wedding gowns. In our online ... for ladies to choose from. What’s more, all of ...
(Date:8/22/2014)... Amy Norton HealthDay Reporter ... growing number of Americans on work disability chronically use ... Researchers found that between 2007 and 2011, about 44 ... were prescribed narcotic painkillers each year. And the percentage ... 2007 to 23 percent in 2011. Experts ...
(Date:8/22/2014)... Health New Orleans School of Nursing was awarded ... increase access to advanced nursing education and patient ... well as veterans. The Health Resources and Services ... Human Services awarded the two-year grant. Scharalda Jeanfreau, ... director., The Advanced Education Nursing Traineeship (AENT) Program ...
(Date:8/22/2014)... 2014 As the controversy surrounding ... in uterine surgeries continues to grow, Bernstein Liebhard ... decided to limit coverage of uterine morcellation. According ... Cross-Blue Shield of Massachusetts will no longer cover ... as of September 1, 2014. Other insurers in ...
Breaking Medicine News(10 mins):Health News:Japantown Dental Introduces Air Polishing 2Health News:Discounted Wedding Gowns For Sale At Leading Online Shop iFitDress.com 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 3Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 4Health News:As Power Morcellator Controversy Grows, Bernstein Liebhard LLP Comments on Massachusetts Insurers’ Plans to Limit Coverage of Uterine Morcellation 2Health News:As Power Morcellator Controversy Grows, Bernstein Liebhard LLP Comments on Massachusetts Insurers’ Plans to Limit Coverage of Uterine Morcellation 3Health News:As Power Morcellator Controversy Grows, Bernstein Liebhard LLP Comments on Massachusetts Insurers’ Plans to Limit Coverage of Uterine Morcellation 4
... to PresentLOS ANGELES, April 27 Aviva ... that provides care and treatment to abandoned, neglected, abused and ... 28, 2009 at The SLS Hotel at Beverly Hills. ... Tracee Ellis Ross, The UXB(R) CEO, NancyJane Goldston and Johnson ...
... NJHA,s Valerie Sellers was a panelist today at an ... New York. The regional workshops, "Standards of Care During ... of Medicine initiative to support the nation,s healthcare providers ... lessons are applicable to an array of health emergencies ...
... (NYSE: NTY ) ( www.NBTY.com ), ... announced that it will web cast the presentation by Harvey ... Barclays Capital 2009 Retail And Restaurants Conference in ... to be web cast live on the Company Web site, ...
... April 27 Susan Brady of MedThink ... in the nation to become certified by the ... organization that provides advocacy and education for medical ... in-depth knowledge and expertise on best practices and ...
... declares a Public Health EmergencyHARRISBURG, Pa., April 27 ... federal officials to contain the impact of an outbreak ... declaration of a national public health emergency in the ... the public and health care providers of recommended steps ...
... health advocacy and qualityOAKLAND, Calif., April 27 ... television commercials to its Thrive advertising ... titled "Mural" and "Kabuki," reinforce Kaiser Permanente,s commitment ... the organization,s dedication to helping its members achieve ...
Cached Medicine News:Health News:Tracee Ellis Ross, NancyJane Goldston & Vicki Martin to be Honored by Aviva Family and Children's Services at The A Party 2Health News:NJHA's Sellers Serves on Institute of Medicine Preparedness Panel 2Health News:NBTY to Webcast Presentation at Barclays Capital 2009 Retail And Restaurants Conference 2Health News:NBTY to Webcast Presentation at Barclays Capital 2009 Retail And Restaurants Conference 3Health News:MedThink Communications Account Director Among First to Receive CMPP Certification in Medical Publications Planning and Development 2Health News:Pennsylvania Working Closely With Federal Partners to Contain Impact of Swine Flu 2Health News:Pennsylvania Working Closely With Federal Partners to Contain Impact of Swine Flu 3Health News:Kaiser Permanente Continues to Spread Health With New Ads Debuting in April 2Health News:Kaiser Permanente Continues to Spread Health With New Ads Debuting in April 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: